Healthlead Public Company Limited
Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies, and medical devices, as well as disinfectant and deodorizing products comprising mask products under the iCare, Pharmax, vitaminclub, … Read more
Healthlead Public Company Limited (HL) - Total Assets
Latest total assets as of September 2025: ฿1.50 Billion THB
Based on the latest financial reports, Healthlead Public Company Limited (HL) holds total assets worth ฿1.50 Billion THB as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Healthlead Public Company Limited - Total Assets Trend (2017–2024)
This chart illustrates how Healthlead Public Company Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Healthlead Public Company Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Healthlead Public Company Limited's total assets of ฿1.50 Billion consist of 57.0% current assets and 43.0% non-current assets.
| Asset Category | Amount (THB) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 11.3% |
| Accounts Receivable | ฿3.65 Million | 0.2% |
| Inventory | ฿290.66 Million | 19.4% |
| Property, Plant & Equipment | ฿0.00 | 0.0% |
| Intangible Assets | ฿9.85 Million | 0.7% |
| Goodwill | ฿15.62 Million | 1.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Healthlead Public Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Healthlead Public Company Limited's current assets represent 57.0% of total assets in 2024, a decrease from 65.4% in 2017.
- Cash Position: Cash and equivalents constituted 11.3% of total assets in 2024, up from 1.6% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 2.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 19.4% of total assets.
Healthlead Public Company Limited Competitors by Total Assets
Key competitors of Healthlead Public Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Healthlead Public Company Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Healthlead Public Company Limited generates 1.32x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Healthlead Public Company Limited generates $5.22 in net profit.
Healthlead Public Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.63 | 3.54 | 1.11 |
| Quick Ratio | 2.35 | 2.26 | 0.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ฿623.88 Million | ฿ 627.89 Million | ฿ 18.68 Million |
Healthlead Public Company Limited - Advanced Valuation Insights
This section examines the relationship between Healthlead Public Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.97 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 8.2% |
| Total Assets | ฿1.50 Billion |
| Market Capitalization | $14.54 Million USD |
Valuation Analysis
Below Book Valuation: The market values Healthlead Public Company Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Healthlead Public Company Limited's assets grew by 8.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Healthlead Public Company Limited (2017–2024)
The table below shows the annual total assets of Healthlead Public Company Limited from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ฿1.50 Billion | +8.18% |
| 2023-12-31 | ฿1.39 Billion | +7.57% |
| 2022-12-31 | ฿1.29 Billion | +15.19% |
| 2021-12-31 | ฿1.12 Billion | +180.84% |
| 2020-12-31 | ฿398.20 Million | +34.25% |
| 2019-12-31 | ฿296.60 Million | +22.13% |
| 2018-12-31 | ฿242.86 Million | -12.42% |
| 2017-12-31 | ฿277.31 Million | -- |